Biopac India Corporation Ltd vs LARSEN & TOUBRO LTD.

A side-by-side comparison of Biopac India Corporation Ltd (532330) and LARSEN & TOUBRO LTD. (LT) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LARSEN & TOUBRO LTD. leads 532330 vs LT on 9 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
32.62
0.00
P/B ratio
5.11
0.00%
Dividend yield
0.98%
₹-6.43
EPS
₹116.92

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

0.00%
Return on equity
15.90%
-54.11%
Return on capital
15.00%
-150.71%
EBITDA margin
12.00%
-225.87%
Net margin
6.63%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
15.96%
Profit CAGR (3Y)
14.79%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹5.25L Cr
₹5 Cr
Revenue
₹2.86L Cr
₹-11 Cr
Net profit
₹18,954 Cr
0.00
Debt / equity
1.15
Biopac India Corporation Ltd
  • ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -39.1% over past five years."]
LARSEN & TOUBRO LTD.
  • + ["Company has been maintaining a healthy dividend payout of 33.1%"]
  • ["Stock is trading at 4.97 times its book value"]
Biopac India Corporation Ltd full analysis LARSEN & TOUBRO LTD. full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

Biopac India Corporation Ltd vs LARSEN & TOUBRO LTD.: Share Price, Valuation & Which to Buy | DocStoX